Seroprevalence of SARS-CoV-2 antibodies in emergency room patients
Conditions
Interventions
Group 1: Seroprevalence of SARS-CoV-2 antibodies in emergency room patients
Sponsors
Institut für Virologie Uniklinik Köln
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: - Age =18 years - Study participants are patients in the emergency room of the university hospital - According to the medical assessment, the information provided and the additional blood collection do not represent any additional burden for the study participants. - Ability to consent and consent to participate in the study. - The ability to consent is checked according to a medical assessment, also with a special focus on the medication, possible pain and the exceptional emotional situation of the patient in an emergency situation and the resulting pressure situation.
Exclusion criteria
Exclusion criteria: - <8 weeks (males) or <12 weeks (females) since last blood volume draw of =500 mL - Inability to give consent - Age <18 years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prevalence of SARS-CoV-2 antibodies in patients in emergency departments at university hospitals in August 2022 | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation of nucleocapsid antibodies for the detection of a past SARS-Cov-2 infections | — |
Countries
Germany
Contacts
Public ContactFelix Dewald
Virologie, Uniklinik Köln
Outcome results
None listed